These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics. Erbak Yılmaz H; Iscan E; Oz O; Batur T; Erdoğan A; Kılıç S; Mutlu Z; Yılmaz M; Spring KJ Mol Biol Rep; 2022 Oct; 49(10):9725-9735. PubMed ID: 35441938 [TBL] [Abstract][Full Text] [Related]
9. An external quality assessment for the molecular testing of the SARS-CoV-2 virus genome in Zhejiang Province, China. Pan J; Yan H; Li Z; Lou X; Mao H; Shi W; Yao W; Zhang Y Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115766. PubMed ID: 36084422 [TBL] [Abstract][Full Text] [Related]
10. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences. Görzer I; Buchta C; Chiba P; Benka B; Camp JV; Holzmann H; Puchhammer-Stöckl E; Aberle SW J Clin Virol; 2020 Aug; 129():104537. PubMed ID: 32659712 [TBL] [Abstract][Full Text] [Related]
11. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States. Fenichel EP; Koch RT; Gilbert A; Gonsalves G; Wyllie AL Microbiol Spectr; 2021 Sep; 9(1):e0031221. PubMed ID: 34378949 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2: Challenges in Reconverting Diagnostic Laboratories to Combat the Pandemic. Barrera Saldaña HA; Rivera Santiago C; Rodríguez Palacios R Microbiol Spectr; 2022 Dec; 10(6):e0147722. PubMed ID: 36314981 [TBL] [Abstract][Full Text] [Related]
13. An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa. Sander AL; Yadouleton A; Moreira-Soto A; Tchibozo C; Hounkanrin G; Badou Y; Fischer C; Krause N; Akogbeto P; F de Oliveira Filho E; Dossou A; Brünink S; Drosten C; Aïssi MAJ; Harouna Djingarey M; Hounkpatin B; Nagel M; Drexler JF mSphere; 2021 Jan; 6(1):. PubMed ID: 33441410 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
16. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand. Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204 [TBL] [Abstract][Full Text] [Related]
17. Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea. Sung H; Han MG; Yoo CK; Lee SW; Chung YS; Park JS; Kim MN; Lee H; Hong KH; Seong MW; Lee K; Chun S; Lee WG; Kwon GC; Min WK Emerg Infect Dis; 2020 Oct; 26(10):2353-2360. PubMed ID: 32723432 [TBL] [Abstract][Full Text] [Related]
18. Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account. Malecki M; Luesebrink J; Wendel AF; Mattner F J Virol Methods; 2021 Sep; 295():114202. PubMed ID: 34087340 [TBL] [Abstract][Full Text] [Related]
19. Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2. Malic L; Brassard D; Da Fonte D; Nassif C; Mounier M; Ponton A; Geissler M; Shiu M; Morton KJ; Veres T Lab Chip; 2022 Aug; 22(17):3157-3171. PubMed ID: 35670202 [TBL] [Abstract][Full Text] [Related]